| Structural Lability of Barley Stripe Mosaic Virus Virions VV Makarov, EV Skurat, PI Semenyuk, DA Abashkin, NO Kalinina, ... PloS one 8 (4), e60942, 2013 | 25 | 2013 |
| Expansion of EasyClone-MarkerFree toolkit for Saccharomyces cerevisiae genome with new integration sites M Babaei, L Sartori, A Karpukhin, D Abashkin, E Matrosova, I Borodina FEMS yeast research 21 (4), foab027, 2021 | 20 | 2021 |
| Cellular models in schizophrenia research DA Abashkin, AO Kurishev, DS Karpov, VE Golimbet International journal of molecular sciences 22 (16), 8518, 2021 | 14 | 2021 |
| A modified protocol of Capture-C allows affordable and flexible high-resolution promoter interactome analysis AK Golov, DA Abashkin, NV Kondratyev, SV Razin, AA Gavrilov, ... Scientific Reports 10 (1), 15491, 2020 | 11 | 2020 |
| Lipophilic poly (glycolide) blocks in morpholin-2-one-based CARTs for plasmid DNA delivery: Polymer regioregularity, sequence of lipophilic/polyamine blocks, and nanoparticle … ED Shaputkin, IE Nifant'ev, VV Bagrov, AV Shlyakhtin, DA Abashkin, ... European Polymer Journal 181, 111644, 2022 | 2 | 2022 |
| ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity DA Abashkin, DS Karpov, AO Kurishev, EV Marilovtseva, VE Golimbet International Journal of Molecular Sciences 24 (21), 15746, 2023 | 1 | 2023 |
| Development of a cellular model to study L-DOPA decarboxylase deregulation in the pathogenesis of schizophrenia A Kurishev, D Abashkin, D Karpov, V Golimbet European Psychiatry 66 (S1), S890-S890, 2023 | | 2023 |
| Development of a self-replicating plasmid for non-toxic expression of CRISPR-repressors to study schizophrenia-risk genes D Abashkin, A Kurishev, D Karpov, V Golimbet European Psychiatry 65 (S1), S152-S152, 2022 | | 2022 |
| W46. CRISPR/CAS9-MEDIATED CREATION OF A CELLULAR MODEL TO INVESTIGATE THE FUNCTION OF EGR1 TRANSCRIPTION FACTOR ASSOCIATED WITH SCHIZOPHRENIA D Abashkin, K Nikolay, G Arkadiy, D Karpov, G Vera European Neuropsychopharmacology 51, e169, 2021 | | 2021 |
| Identification of potential enhancers contributed to the schizophrenia pathogenesis D Abashkin, N Kondratyev, A Golov, D Karpov, V Golimbet FEBS OPEN BIO 11, 284-284, 2021 | | 2021 |
| Epigenome editing of the potential enhancers of the schizophrenia risk genes. D Abashkin, N Kondratyev, A Golov, D Karpov, S Smirnova, T Lezheiko, ... European Psychiatry 63, 2020 | | 2020 |
| Post-GWAS studies of schizophrenia VE Golimbet, AK Golov, GY Tsarapkin, NV Kondratyev, AS Tovmasyan, ... Medical Genetics 19 (4), 5-6, 2020 | | 2020 |
| Epigenome editing of the potential enhancers of the schizophrenia risk genes: approaches for optimization of the genetic constructs DA Abashkin, AO Kurishev, SV Smirnova, DS Karpov, VE Golimbet VM BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, 103-105, 2019 | | 2019 |
Karpov DmitryEngelhardt Institute of Molecular Biology RASVerified email at eimb.ru
